Macquarie Group Ltd
Source: SEC Form 13F · as of Mar 2026Macquarie Group Ltd holds 10 biotech & pharma companies tracked by BioSniper, totaling $169.2M in value as of Mar 2026 (SEC Form 13F).
Companies held
10
Total value held
$169.2M
BioSniper AIPage context preserved
Prepared research question
What matters most for GILEAD SCIENCES, INC. (GILD)—catalysts, financial risk and supporting evidence?
Run cited research
Traceable citations · Unknowns marked
| Company | Shares | Value |
|---|---|---|
| GILDGILEAD SCIENCES, INC. | 1,010,606 | $140.8M |
| REGNREGENERON PHARMACEUTICALS, INC. | 13,050 | $10.1M |
| ALNYALNYLAM PHARMACEUTICALS, INC. | 16,047 | $5.3M |
| EXELEXELIXIS, INC. | 113,230 | $4.9M |
| INCYIncyte Corp. | 39,159 | $3.7M |
| TEVATeva Pharmaceutical Industries Limited | 50,339 | $1.5M |
| SIGASIGA TECHNOLOGIES INC | 244,853 | $1.3M |
| INSMINSMED Inc | 5,193 | $849K |
| MRNAModerna, Inc. | 8,005 | $407K |
| RVMDREVOLUTION MEDICINES, INC. | 3,331 | $324K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.